StockData
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. (NAGE) stock

NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3015% below fair value
$1.94−0.10 (-4.90%)

Close on Nov 18, 2026Market cap $153.50MP/E 16.2Yield –

Niagen Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Niagen Bioscience's price to book ratio was 2.0× on Nov 11, 2026, against 7.6× a year earlier. Over the last 5 years it ranged from 2.0× to 20.4×, with a median of 5.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.0×−5.2
2025Dec 31, 20257.2×−4.6
2024Dec 31, 202411.7×+7.8
2023Dec 29, 20233.9×−1.5
2022Dec 30, 20225.4×−1.7
2021Dec 31, 20217.2×+7.2
2020Dec 31, 20200.0×+0.0
2019Dec 31, 20190.0×+0.0
2018Dec 31, 20180.0×−8.3
2017Dec 29, 20178.3×−2.2
2016Dec 30, 201610.5×−22.8
2015Dec 31, 201533.3×+11.9
2014Dec 31, 201421.3×−13.7
2013Dec 31, 201335.1×+25.8
2012Dec 31, 20129.3×+0.5
2011Dec 30, 20118.8×–

More Niagen Bioscience figures

See a number that looks wrong?